Suivre
Sylvie DUCKI
Sylvie DUCKI
SIGMA Clermont
Adresse e-mail validée de sigma-clermont.fr
Titre
Citée par
Citée par
Année
Potent antimitotic and cell growth inhibitory properties of substituted chalcones
S Ducki, R Forrest, JA Hadfield, A Kendall, NJ Lawrence, AT McGown, ...
Bioorganic & medicinal chemistry letters 8 (9), 1051-1056, 1998
5371998
Tubulin and microtubules as targets for anticancer drugs
JA Hadfield, S Ducki, N Hirst, AT McGown
Progress in Cell Cycle Research. 5, 309-326, 2003
3532003
Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity
S Ducki, D Rennison, M Woo, A Kendall, JFD Chabert, AT McGown, ...
Bioorganic & medicinal chemistry 17 (22), 7698-7710, 2009
2382009
1, 5-Disubstituted 1, 2, 3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin
K Odlo, J Hentzen, JF dit Chabert, S Ducki, OA Gani, I Sylte, M Skrede, ...
Bioorganic & medicinal chemistry 16 (9), 4829-4838, 2008
2142008
Effects of α-substitutions on structure and biological activity of anticancer chalcones
NJ Lawrence, RP Patterson, LL Ooi, D Cook, S Ducki
Bioorganic & medicinal chemistry letters 16 (22), 5844-5848, 2006
2022006
The interaction of chalcones with tubulin
NJ Lawrence, AT McGown, S Ducki, JA Hadfield
Anti-cancer drug design 15 (2), 135-141, 2000
1482000
Antimitotic chalcones and related compounds as inhibitors of tubulin assembly
S Ducki
Anti-cancer agents in medicinal chemistry 9 (3), 336, 2009
1392009
Linked parallel synthesis and MTT bioassay screening of substituted chalcones
NJ Lawrence, D Rennison, AT McGown, S Ducki, LA Gul, JA Hadfield, ...
Journal of combinatorial chemistry 3 (5), 421-426, 2001
1292001
Evaluation of solid-phase micro-extraction coupled to gas chromatography–mass spectrometry for the headspace analysis of volatile compounds in cocoa products
S Ducki, J Miralles-Garcia, A Zumbé, A Tornero, DM Storey
Talanta 74 (5), 1166-1174, 2008
1242008
Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones
S Ducki, G Mackenzie, B Greedy, S Armitage, JFD Chabert, E Bennett, ...
Bioorganic & medicinal chemistry 17 (22), 7711-7722, 2009
1132009
The development of chalcones as promising anticancer agents
S Ducki
IDrugs 10 (1), 42, 2007
1132007
1, 2, 3-Triazole analogs of combretastatin A-4 as potential microtubule-binding agents
K Odlo, J Fournier-Dit-Chabert, S Ducki, OA Gani, I Sylte, TV Hansen
Bioorganic & medicinal chemistry 18 (18), 6874-6885, 2010
1032010
Quantitative structure− activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly
S Ducki, G Mackenzie, NJ Lawrence, JP Snyder
Journal of medicinal chemistry 48 (2), 457-465, 2005
912005
Isolation of E-1-(4′-Hydroxyphenyl)-but-1-en-2-one from Scutellaria barbata
S Ducki, JA Hadfield, NJ Lawrence, CY Liu, AT McGown, X Zhang
Planta Medica 62 (02), 185-186, 1996
761996
Asymmetric alkylation of diarylmethane derivatives
JA Wilkinson, SB Rossington, S Ducki, J Leonard, N Hussain
Tetrahedron 62 (8), 1833-1844, 2006
712006
Antineoplastic Agents. 454. Synthesis of the Strong Cancer Cell Growth Inhibitors trans-Dihydronarciclasine and 7-Deoxy-trans-dihydronarciclasine
GR Pettit, S Ducki, SA Eastham, N Melody
Journal of natural products 72 (7), 1279-1282, 2009
682009
An ethnobotanical and phytochemical study of the African medicinal plant Guiera senegalensis JF Gmel
AA Somboro, K Patel, D Diallo, L Sidibe, JC Chalchat, G Figueredo, ...
Journal of Medicinal Plants Research 5 (9), 1639-1651, 2011
652011
The synthesis of indanones related to combretastatin A-4 via microwave-assisted Nazarov cyclization of chalcones
NJ Lawrence, ESM Armitage, B Greedy, D Cook, S Ducki, AT McGown
Tetrahedron letters 47 (10), 1637-1640, 2006
642006
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity
D Vivier, IB Soussia, N Rodrigues, S Lolignier, M Devilliers, FC Chatelain, ...
Journal of medicinal chemistry 60 (3), 1076-1088, 2017
592017
Assessing the dual activity of a chalcone–phthalocyanine conjugate: Design, synthesis, and antivascular and photodynamic Properties
S Tuncel, A Trivella, D Atilla, K Bennis, H Savoie, F Albrieux, L Delort, ...
Molecular Pharmaceutics 10 (10), 3706-3716, 2013
552013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20